Skip to content

Clinical trials

Phase 3 Neurologic Manifestations trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurologic Manifestations Phase: Phase 3 Country / region: Canada Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20162
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Auris Medical, Inc.1
Bayer1
Eli Lilly and Company1
Laboratoires Thea1
Medicure1
Taysha Gene Therapies, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurologic Manifestations6
Nervous System Diseases3
Sensation Disorders2
Blindness1
Brain Diseases1
Central Nervous System Diseases1
Cluster Headache1
Communicable Diseases1
Congenital, Hereditary, and Neonatal Diseases and Abnormalities1
Deafness1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.